ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,241Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 36

$542K Total Retail Price of All Prescriptions

Rank: 15 out of 36

333 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 333 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 6,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 350 287 1 1
METFORMIN HCL 195 145 2 11
LOSARTAN POTASSIUM 182 165 3 23
OMEPRAZOLE 176 143 4 6
GABAPENTIN 165 128 5 10
FUROSEMIDE 158 130 6 5
HYDROCODONE-ACETAMINOPHEN 156 117 S3 7 7
SIMVASTATIN 154 117 8 2
LOVASTATIN 154 117 8 62
LISINOPRIL 151 115 10 3
CARVEDILOL 147 128 11 20
PANTOPRAZOLE SODIUM 138 113 12 35
LEVOTHYROXINE SODIUM 129 114 13 4
LOSARTAN-HYDROCHLOROTHIAZIDE 129 88 13 63
METOPROLOL SUCCINATE 118 87 15 18
NAMENDA 116 116 16 13
METOPROLOL TARTRATE 108 100 17 8
TRAMADOL HCL 108 89 17 14
DONEPEZIL HCL 107 102 19 12
ATORVASTATIN CALCIUM 104 92 20 22
TAMSULOSIN HCL 102 84 21 41
ZOLPIDEM TARTRATE 102 63 21 24
TRAMADOL HCL-ACETAMINOPHEN 100 62 23 117
PRAVASTATIN SODIUM 99 76 24 21
SERTRALINE HCL 88 79 25 19
GLIMEPIRIDE 86 62 26 46
SYMBICORT 84 46 27 122
TERAZOSIN HCL 80 67 28 84
TRAZODONE HCL 78 65 29 39
PAROXETINE HCL 75 58 30 57
RANITIDINE HCL 74 52 31 25
HYDRALAZINE HCL 73 70 32 29
ALENDRONATE SODIUM 72 60 33 34
PROAIR HFA 71 37 34 68
CLOPIDOGREL 71 55 34 33
CLONIDINE HCL 70 63 36 50
PREDNISONE 70 49 36 59
CRESTOR 67 61 38 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 29 39 106
BENAZEPRIL HCL 61 40 40 114
QUETIAPINE FUMARATE 60 60 41 37
ALLOPURINOL 57 55 42 44
ADVAIR DISKUS 56 47 43 70
CITALOPRAM HBR 55 38 44 16
DIOVAN 55 50 44 40
CYMBALTA 54 36 46 48
LANTUS 52 37 47 38
FLUTICASONE PROPIONATE 51 26 48 45
VENTOLIN HFA 51 36 48 139
CIPROFLOXACIN HCL 51 44 48 60
AZITHROMYCIN 50 34 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.